Global patterns in excess body weight and the associated cancer burden

CA Cancer Journal for Clinicians

Volumn 69, Issue 2, 2019, Pages 88-112

  Sung, Hyuna ^a   Siegel, Rebecca L ^a   Torre, Lindsey A ^a   Pearson Stuttard, Jonathan ^b   Islami, Farhad ^a   Fedewa, Stacey A ^a   Goding Sauer, Ann ^a   Shuval, Kerem ^c   Gapstur, Susan M ^a   Jacobs, Eric J ^a   Giovannucci, Edward L ^d   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Economic and Health Policy Research Program   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

adiposity; body fatness; cancer; cancer burden; cancer incidence; excess body weight; global obesity epidemic; overweight; population attributable fraction; prevalence

Indexed keywords

ADVANCED CANCER; AFRICA; ARTICLE; ASIA; BODY MASS; BODY WEIGHT CONTROL; BODY WEIGHT LOSS; BREAST CANCER; CALORIC INTAKE; CANCER LOCALIZATION; CANCER RISK; CANCER SURVIVAL; COLON CANCER; CONSENSUS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ESOPHAGEAL ADENOCARCINOMA; FOOD COMPOSITION; FOOD QUALITY; GALLBLADDER CANCER; GLOBAL DISEASE BURDEN; HEALTH CARE POLICY; HIGH INCOME COUNTRY; HUMAN; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; LOW INCOME COUNTRY; MALIGNANT NEOPLASM; MENINGIOMA; MIDDLE EAST; MIDDLE INCOME COUNTRY; MOUTH CANCER; MULTIPLE MYELOMA; NORTH AFRICA; NUTRIENT; OBESITY; OVARY CANCER; PANCREAS CANCER; PANDEMIC; PATHOPHYSIOLOGY; PHARYNX CANCER; PHYSICAL ACTIVITY; POPULATION GROWTH; POPULATION RESEARCH; POPULATION SIZE; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RISK FACTOR; SEX DIFFERENCE; SMOKING; STOMACH CANCER; THYROID CANCER; TREND STUDY; WESTERN WORLD; COMPLICATION; COST OF ILLNESS; FEMALE; GLOBAL HEALTH; MALE; NEOPLASM; SEX FACTOR;

BODY MASS INDEX; COST OF ILLNESS; FEMALE; GLOBAL HEALTH; HUMANS; MALE; NEOPLASMS; OBESITY; OVERWEIGHT; PREVALENCE; RISK FACTORS; SEX FACTORS;

EID: 85058423281     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21499     Document Type: Article

References (191)

1. World Health Organization. Obesity and Overweight Fact Sheet. Geneva, Switzerland: World Health Organization; 2018. who.int/mediacentre/factsheets/fs311/en/. Accessed July 1, 2018.
2. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13-27.
3. Dobbs R, Sawers C, Thompson F, et al. Overcoming Obesity: An Initial Economic Analysis. New York: McKinsey Global Institute; 2014. mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-the-world-could-better-fight-obesity. Accessed July 1, 2018.
4. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627-2642.
5. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33:673-689.
6. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer — viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794-798.
7. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report 2018. Body Fatness and Weight Gain and the Risk of Cancer. London, UK: World Cancer Research Fund International; 2018. wcrf.org/sites/default/files/Body-fatness-and-weight-gain.pdf. Accessed July 1, 2018.
8. Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol. 2018;6:e6-e15.
9. Bandera EV, Fay SH, Giovannucci E, et al. The use and interpretation of anthropometric measures in cancer epidemiology: a perspective from the World Cancer Research Fund International Continuous Update Project. Int J Cancer. 2016;139:2391-2397.
10. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660-667.
11. Obesity Prevention Source, Harvard T.H. Chan School of Public Health. Defining Childhood Obesity. Boston, MA: Harvard T.H. Chan School of Public Health; 2018. hsph.harvard.edu/obesity-prevention-source/obesity-definition/defining-childhood-obesity/. Accessed July 1, 2018.
12. Song Y, Wang HJ, Dong B, Ma J, Wang Z, Agardh A. 25-year trends in gender disparity for obesity and overweight by using WHO and IOTF definitions among Chinese school-aged children: a multiple cross-sectional study [serial online]. BMJ Open. 2016;6:e011904.
13. Rito A, Wijnhoven TM, Rutter H, et al. Prevalence of obesity among Portuguese children (6–8 years old) using three definition criteria: COSI Portugal, 2008. Pediatr Obes. 2012;7:413-422.
14. Wang Y, Wang JQ. Standard definition of child overweight and obesity worldwide. Authors' standard compares well with WHO standard [serial online]. BMJ. 2000;321:1158.
15. Willett WC, Hu F. Anthropometric measures and body composition. In: Willett W, ed. Nutritional Epidemiology. New York: Oxford University Press; 1993:213-259.
16. Ode JJ, Pivarnik JM, Reeves MJ, Knous JL. Body mass index as a predictor of percent fat in college athletes and nonathletes. Med Sci Sports Exerc. 2007;39:403-409.
17. Hu F. Chapter 5. Measurements of adiposity and body composition. In: Hu F, ed. Obesity Epidemiology. New York: Oxford University Press; 2008:53-83. hsph.harvard.edu/nutritionsource/2008/03/21/obesity-epidemiology/. Accessed July 1, 2018.
18. Shah AD, Kandula NR, Lin F, et al. Less favorable body composition and adipokines in South Asians compared with other US ethnic groups: results from the MASALA and MESA studies. Int J Obes (Lond). 2016;40:639-645.
19. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr. 2007;86:353-359.
20. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
21. Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation. 2007;115:2111-2118.
22. Gujral UP, Vittinghoff E, Mongraw-Chaffin M, et al. Cardiometabolic abnormalities among normal-weight persons from five racial/ethnic groups in the United States: a cross-sectional analysis of two cohort studies. Ann Intern Med. 2017;166:628-636.
23. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129-2140.
24. Iyengar NM, Zhou XK, Gucalp A, et al. Systemic correlates of white adipose tissue inflammation in early-stage breast cancer. Clin Cancer Res. 2016;22:2283-2289.
25. Mullooly M, Yang HP, Falk RT, et al. Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients [serial online]. Breast Cancer Res. 2017;19:8.
26. Michelotti GA, Machado MV, Diehl AM. NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol. 2013;10:656-665.
27. Sijens PE, Edens MA, Bakker SJ, Stolk RP. MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol. 2010;16:1993-1998.
28. Hori M, Takahashi M, Hiraoka N, et al. Association of pancreatic fatty infiltration with pancreatic ductal adenocarcinoma [serial online]. Clin Transl Gastroenterol. 2014;5:e53.
29. Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer. 2015;15:484-498.
30. Thanassoulis G, Massaro JM, Hoffmann U, et al. Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study. Circ Cardiovasc Imaging. 2010;3:559-566.
31. UK BioBank. Imaging Data. Stockport, UK: UK BioBank; 2018. ukbiobank.ac.uk/imaging-data/. Accessed July 26, 2018.
32. Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378:804-814.
33. Sacks G, Swinburn B, Lawrence M. Obesity Policy Action framework and analysis grids for a comprehensive policy approach to reducing obesity. Obes Rev. 2009;10:76-86.
34. Rokholm B, Baker JL, Sorensen TI. The levelling off of the obesity epidemic since the year 1999—a review of evidence and perspectives. Obes Rev. 2010;11:835-846.
35. Masood M, Reidpath DD. Effect of national wealth on BMI: an analysis of 206,266 individuals in 70 low-, middle- and high-income countries [serial online]. PLoS One. 2017;12:e0178928.
36. Smith N. Big Government, Small Bellies: What Japan Can Teach Us About Fighting Fat. The Atlantic. September 6, 2012. theatlantic.com/health/archive/2012/09/big-government-small-bellies-what-japan-can-teach-us-about-fighting-fat/261940/. Accessed July 1, 2018.
37. Lee MJ, Popkin BM, Kim S. The unique aspects of the nutrition transition in South Korea: the retention of healthful elements in their traditional diet. Public Health Nutr. 2002;5:197-203.
38. Senauer B, Gemma M. Why Is the Obesity Rate So Low in Japan and High in the US? Some Possible Economic Explanations. Working Paper 06–02. St Paul, MN: The Food Industry Center, University of Minnesota; 2006. ageconsearch.umn.edu/record/14321/files/tr06-02s.pdf?version=1. Accessed July 1, 2018.
39. Rodgers A, Woodward A, Swinburn B, Dietz WH. Prevalence trends tell us what did not precipitate the US obesity epidemic. Lancet Public Health. 2018;3:e162-e163.
40. Schmidhuber J, Sur P, Fay K, et al. The Global Nutrient Database: availability of macronutrients and micronutrients in 195 countries from 1980 to 2013. Lancet Planet Health. 2018;2:e353-e368.
41. Swinburn B, Sacks G, Ravussin E. Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr. 2009;90:1453-1456.
42. Scarborough P, Burg MR, Foster C, et al. Increased energy intake entirely accounts for increase in body weight in women but not in men in the UK between 1986 and 2000. Br J Nutr. 2011;105:1399-1404.
43. Young LR, Nestle M. Expanding portion sizes in the US marketplace: implications for nutrition counseling. J Am Diet Assoc. 2003;103:231-234.
44. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537-543.
45. Andersen LB, Mota J, DiPietro L. Update on the global pandemic of physical inactivity. Lancet. 2016;388:1255-1256.
46. Giovannucci E. An integrative approach for deciphering the causal associations of physical activity and cancer risk: the role of adiposity. J Natl Cancer Inst. 2018;110:935-941.
47. Ng SW, Popkin BM. Time use and physical activity: a shift away from movement across the globe. Obes Rev. 2012;13:659-680.
48. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635-643.
49. Pickett KE, Kelly S, Brunner E, Lobstein T, Wilkinson RG. Wider income gaps, wider waistbands? An ecological study of obesity and income inequality. J Epidemiol Community Health. 2005;59:670-674.
50. Su D, Esqueda OA, Li L, Pagan JA. Income inequality and obesity prevalence among OECD countries. J Biosoc Sci. 2012;44:417-432.
51. Organisation for Economic Cooperation and Development (OECD). OECD Obesity Update 2017: Paris, France: Organisation for Economic Cooperation and Development; 2017. oecd.org/health/health-systems/obesity-update.htm. Accessed July 1, 2018.
52. Loring B, Robertson A. Obesity and Inequities. Guidance for Addressing Inequities in Overweight and Obesity (2014). Copenhagen, Denmark: World Health Organization Regional Office for Europe; 2014. euro.who.int/en/publications/abstracts/obesity-and-inequities.-guidance-for-addressing-inequities-in-overweight-and-obesity-2014. Accessed July 1, 2018.
53. Robertson A, Lobstein T, Knai C. Obesity and Socio-Economic Groups in Europe: Evidence Review and Implications for Action. Brussels, Belgium: European Commission; 2007. ec.europa.eu/health/ph_determinants/life_style/nutrition/documents/ev20081028_rep_en.pdf. Accessed July 1, 2018.
54. Hwalla N, Nasreddine L, ElLabban S. Chapter 8. Cultural determinants of obesity in low- and middle-income countries in the Eastern Mediterranean Region. In: Romieu I, Dossus L, Willet WC, eds. Energy Balance and Obesity. IARC Working Group Reports, Volume 10. Lyon, France, IARC Press; 2017:57-67. publications.iarc.fr/Book-And-Report-Series/Iarc-Working-Group-Reports/Energy-Balance-And-Obesity-2017. Accessed July 1, 2018.
55. Musaiger AO, Shahbeek NE, Al-Mannai M. The role of social factors and weight status in ideal body-shape preferences as perceived by Arab women. J Biosoc Sci. 2004;36:699-707.
56. Mavoa HM, McCabe M. Sociocultural factors relating to Tongans' and indigenous Fijians' patterns of eating, physical activity and body size. Asia Pac J Clin Nutr. 2008;17:375-384.
57. Burke MA, Heiland FW. Evolving societal norms of obesity: what is the appropriate response? JAMA. 2018;319:221-222.
58. Hayashi F, Takimoto H, Yoshita K, Yoshiike N. Perceived body size and desire for thinness of young Japanese women: a population-based survey. Br J Nutr. 2006;96:1154-1162.
59. Marini M, Sriram N, Schnabel K, et al. Overweight people have low levels of implicit weight bias, but overweight nations have high levels of implicit weight bias [serial online]. PLoS One. 2013;8:e83543.
60. Al Nohair S. Obesity in gulf countries. Int J Health Sci (Qassim). 2014;8:79-83.
61. Sallis JF, Floyd MF, Rodriguez DA, Saelens BE. Role of built environments in physical activity, obesity, and cardiovascular disease. Circulation. 2012;125:729-737.
62. Papas MA, Alberg AJ, Ewing R, Helzlsouer KJ, Gary TL, Klassen AC. The built environment and obesity. Epidemiol Rev. 2007;29:129-143.
63. Bell AC, Ge K, Popkin BM. The road to obesity or the path to prevention: motorized transportation and obesity in China. Obes Res. 2002;10:277-283.
64. Sallis JF, Bowles HR, Bauman A, et al. Neighborhood environments and physical activity among adults in 11 countries. Am J Prev Med. 2009;36:484-490.
65. Shuval K, Leonard T, Drope J, et al. Physical activity counseling in primary care: Insights from public health and behavioral economics. CA Cancer J Clin. 2017;67:233-244.
66. European Cyclists’ Federation. National Cycling Policies. Brussels, Belgium: European Cyclists’ Federation; 2018. ecf.com/what-we-do/cycling-all-policies/national-cycling-policies. Accessed July 1, 2018.
67. Fishman E, Bocker L, Helbich M. Adult active transport in the Netherlands: an analysis of its contribution to physical activity requirements [serial online]. PLoS One. 2015;10:e0121871.
68. Pucher J, Buehler R. At the frontiers of cycling: policy innovations in the Netherlands, Denmark, and Germany. World Transport Policy Pract. 2007;13:8-57.
69. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med. 1990;322:1483-1487.
70. Zaitlen N, Kraft P, Patterson N, et al. Using extended genealogy to estimate components of heritability for 23 quantitative and dichotomous traits [serial online]. PLoS Genet. 2013;9:e1003520.
71. Russo P, Lauria F, Siani A. Heritability of body weight: moving beyond genetics. Nutr Metab Cardiovasc Dis. 2010;20:691-697.
72. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197-206.
73. Minster RL, Hawley NL, Su CT, et al. A thrifty variant in CREBRF strongly influences body mass index in Samoans. Nat Genet. 2016;48:1049-1054.
74. Holmes D. Obesity: BMI-increasing variant identified in Samoans. Nat Rev Endocrinol. 2016;12:560.
75. Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16:36-46.
76. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report 2018. Diet, Nutrition, Physical Activity and Breast Cancer. London, UK: World Cancer Research Fund International; 2016. wcrf.org/dietandcancerreport.org. Accessed July 1, 2018.
77. Keum N, Greenwood DC, Lee DH, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies [serial online]. J Natl Cancer Inst. 2015;107:djv088.
78. Rosner B, Eliassen AH, Toriola AT, et al. Weight and weight changes in early adulthood and later breast cancer risk. Int J Cancer. 2017;140:2003-2014.
79. Chen Q, Wang J, Yang J, et al. Association between adult weight gain and colorectal cancer: a dose-response meta-analysis of observational studies. Int J Cancer. 2015;136:2880-2889.
80. Zhang X, Wu K, Giovannucci EL, et al. Early life body fatness and risk of colorectal cancer in US women and men—results from two large cohort studies. Cancer Epidemiol Biomarkers Prev. 2015;24:690-697.
81. Keum N, Lee DH, Kim R, Greenwood DC, Giovannucci EL. Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies. Ann Oncol. 2015;26:1101-1109.
82. Oh TH, Byeon JS, Myung SJ, et al. Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol. 2008;23:411-417.
83. Schlesinger S, Lieb W, Koch M, et al. Body weight gain and risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Obes Rev. 2015;16:607-619.
84. Kim H, Giovannucci EL. Sex differences in the association of obesity and colorectal cancer risk. Cancer Causes Control. 2017;28:1-4.
85. Setiawan VW, Yang HP, Pike MC, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31:2607-2618.
86. Aune D, Navarro Rosenblatt DA, Chan DS, et al. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Ann Oncol. 2015;26:1635-1648.
87. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19:3119-3130.
88. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report 2016: Diet, Nutrition, Physical Activity and Oesophageal Cancer. London, UK: World Cancer Research Fund International; 2016. wcrf.org/oesophageal-cancer-2016. Accessed July 1, 2018.
89. Kardan A, Satter M. Methionine PET—overview and application to brain tumor imaging and treatment. In: NewtonHB, ed. Handbook of Neuro-Oncology Neuroimaging. 2nd ed. New York: Academic Press; 2016:371-384.
90. Niedermaier T, Behrens G, Schmid D, Schlecht I, Fischer B, Leitzmann MF. Body mass index, physical activity, and risk of adult meningioma and glioma: a meta-analysis. Neurology. 2015;85:1342-1350.
91. Sergentanis TN, Tsivgoulis G, Perlepe C, et al. Obesity and risk for brain/CNS tumors, gliomas and meningiomas: a meta-analysis [serial online]. PLoS One. 2015;10:e0136974.
92. Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer. 2011;47:1606-1615.
93. Marinac CR, Birmann BM, Lee IM, et al. Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts. Br J Cancer. 2018;118:1013-1019.
94. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies [serial online]. PLoS Med. 2012;9:e1001200.
95. Olsen CM, Nagle CM, Whiteman DC, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer. 2013;20:251-262.
96. Genkinger JM, Spiegelman D, Anderson KE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2011;129:1708-1717.
97. Genkinger JM, Kitahara CM, Bernstein L, et al. Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol. 2015;26:2257-2266.
98. Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015;64:1881-1888.
99. Chen Y, Liu L, Wang X, et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev. 2013;22:1395-1408.
100. Lin XJ, Wang CP, Liu XD, et al. Body mass index and risk of gastric cancer: a meta-analysis. Jpn J Clin Oncol. 2014;44:783-791.
101. Kitahara CM, McCullough ML, Franceschi S, et al. Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies. Thyroid. 2016;26:306-318.
102. Gaudet MM, Kitahara CM, Newton CC, et al. Anthropometry and head and neck cancer: a pooled analysis of cohort data. Int J Epidemiol. 2015;44:673-681.
103. Moller E, Adami HO, Mucci LA, et al. Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden. Cancer Causes Control. 2013;24:2143-2155.
104. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014;384:755-765.
105. El-Zein M, Parent ME, Nicolau B, Koushik A, Siemiatycki J, Rousseau MC. Body mass index, lifetime smoking intensity and lung cancer risk. Int J Cancer. 2013;133:1721-1731.
106. Smith L, Brinton LA, Spitz MR, et al. Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst. 2012;104:778-789.
107. Lahmann PH, Pandeya N, Webb PM, Green AC, Whiteman DC. Australian Cancer Society. Body mass index, long-term weight change, and esophageal squamous cell carcinoma: is the inverse association modified by smoking status? Cancer. 2012;118:1901-1909.
108. Song M, Giovannucci E. Estimating the influence of obesity on cancer risk: stratification by smoking is critical. J Clin Oncol. 2016;34:3237-3239.
109. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87:801-809.
110. Henley SJ, Flanders WD, Manatunga A, Thun MJ. Leanness and lung cancer risk: fact or artifact? Epidemiology. 2002;13:268-276.
111. Canoy D, Wareham N, Luben R, et al. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res. 2005;13:1466-1475.
112. Pan A, Wang Y, Talaei M, Hu FB, Wu T. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3:958-967.
113. Gao C, Patel CJ, Michailidou K, et al. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int J Epidemiol. 2016;45:896-908.
114. Etemadi A, Golozar A, Kamangar F, et al. Large body size and sedentary lifestyle during childhood and early adulthood and esophageal squamous cell carcinoma in a high-risk population. Ann Oncol. 2012;23:1593-1600.
115. Park Y, Colditz GA. Diabetes and adiposity: a heavy load for cancer. Lancet Diabetes Endocrinol. 2018;6:82-83.
116. Keum N, Song M, Giovannucci ED, Eliassen AH. Chapter 20. Obesity and body composition. In: Thun M, Linet MS, Cerhan JR, Haiman CA, Shottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2017:351-376.
117. Clarke MA, Joshu CE. Early life exposures and adult cancer risk. Epidemiol Rev. 2017;39:11-27.
118. Hidayat K, Yang CM, Shi BM. Body fatness at an early age and risk of colorectal cancer. Int J Cancer. 2018;142:729-740.
119. Levi Z, Kark JD, Katz LH, et al. Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: a population-based study. Cancer. 2017;123:4022-4030.
120. Dougan MM, Hankinson SE, Vivo ID, Tworoger SS, Glynn RJ, Michels KB. Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. Int J Cancer. 2015;137:625-637.
121. Yang TY, Cairns BJ, Allen N, et al. Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Br J Cancer. 2012;107:169-175.
122. Park SL, Goodman MT, Zhang ZF, Kolonel LN, Henderson BE, Setiawan VW. Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int J Cancer. 2010;126:490-499.
123. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569-578.
124. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348:1625-1638.
125. Hopkins BD, Goncalves MD, Cantley LC. Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol. 2016;34:4277-4283.
126. Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015;95:727-748.
127. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363:1346-1353.
128. Green J, Cairns BJ, Casabonne D, et al. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011;12:785-794.
129. Carreras-Torres R, Johansson M, Gaborieau V, et al. The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a Mendelian randomization study [serial online]. J Natl Cancer Inst. 2017;109:djx012.
130. Nead KT, Sharp SJ, Thompson DJ, et al. Evidence of a causal association between insulinemia and endometrial cancer: a Mendelian randomization analysis [serial online]. J Natl Cancer Inst. 2015;107:djv178.
131. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33:1674-1685.
132. Bulun SE, Chen D, Moy I, Brooks DC, Zhao H. Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab. 2012;23:83-89.
133. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95:1218-1226.
134. Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;63:800-809.
135. Williams G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-alpha and GPER signalling. Mol Cell Endocrinol. 2012;351:269-278.
136. Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev. 2007;29:88-97.
137. Platz EA, Leitzmann MF, Rifai N, et al. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev. 2005;14:1262-1269.
138. Severi G, Morris HA, MacInnis RJ, et al. Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:86-91.
139. Hursting SD, Digiovanni J, Dannenberg AJ, et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila). 2012;5:1260-1272.
140. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002;290:1084-1089.
141. Lee CH, Woo YC, Wang Y, Yeung CY, Xu A, Lam KS. Obesity, adipokines and cancer: an update. Clin Endocrinol (Oxf). 2015;83:147-156.
142. Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33:547-594.
143. Liu LY, Wang M, Ma ZB, et al. The role of adiponectin in breast cancer: a meta-analysis [serial online]. PLoS One. 2013;8:e73183.
144. Katira A, Tan PH. Evolving role of adiponectin in cancer-controversies and update. Cancer Biol Med. 2016;13:101-119.
145. Liao LM, Weinstein SJ, Pollak M, et al. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis. 2013;34:109-112.
146. Milic S, Lulic D, Stimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20:9330-9337.
147. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354:2340-2348.
148. Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA. 2013;310:627-636.
149. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med. 1989;321:563-569.
150. Espinoza JA, Bizama C, Garcia P, et al. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta. 2016;1865:245-254.
151. Jackson SE, Heinrich M, Beeken RJ. Wardle J Weight loss and mortality in overweight and obese cancer survivors: a systematic review [serial online]. PLoS One. 2017;12:e0169173.
152. Birks S, Peeters A, Backholer K, O'Brien P, Brown W. A systematic review of the impact of weight loss on cancer incidence and mortality. Obes Rev. 2012;13:868-891.
153. MacLean PS, Wing RR, Davidson T, et al. NIH working group report: innovative research to improve maintenance of weight loss. Obesity (Silver Spring). 2015;23:7-15.
154. Sjostrom L, Gummesson A, Sjostrom CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10:653-662.
155. Christou NV, Lieberman M, Sampalis F, Sampalis JS. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008;4:691-695.
156. Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17:796-802.
157. Parker ED, Folsom AR. Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study. Int J Obes Relat Metab Disord. 2003;27:1447-1452.
158. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40–64 years. Am J Epidemiol. 1995;141:1128-1141.
159. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in overweight white men aged 40–64 years. Am J Epidemiol. 1999;149:491-503.
160. Strulov Shachar S, Williams GR. The obesity paradox in cancer—moving beyond BMI. Cancer Epidemiol Biomarkers Prev. 2017;26:13-16.
161. Demark-Wahnefried W, Platz EA, Ligibel JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev. 2012;21:1244-1259.
162. Niraula S, Ocana A, Ennis M, Goodwin PJ. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat. 2012;134:769-781.
163. Chan DS, Vieira AR, Aune D, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25:1901-1914.
164. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123:627-635.
165. Jiralerspong S, Goodwin PJ. Obesity and breast cancer prognosis: evidence, challenges, and opportunities. J Clin Oncol. 2016;34:4203-4216.
166. Guo Q, Burgess S, Turman C, et al. Body mass index and breast cancer survival: a Mendelian randomization analysis. Int J Epidemiol. 2017;46:1814-1822.
167. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23:1370-1378.
168. Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis [serial online]. J Natl Cancer Inst. 2015;107:djv275.
169. Chen X, Lu W, Zheng W, et al. Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat. 2010;122:823-833.
170. Cespedes Feliciano EM, Kroenke CH, Bradshaw PT, et al. Postdiagnosis weight change and survival following a diagnosis of early-stage breast cancer. Cancer Epidemiol Biomarkers Prev. 2017;26:44-50.
171. Caan BJ, Cespedes Feliciano EM, Prado CM, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol. 2018;4:798-804.
172. Zhang X, Zhou G, Sun B, et al. Impact of obesity upon prostate cancer-associated mortality: a meta-analysis of 17 cohort studies. Oncol Lett. 2015;9:1307-1312.
173. Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2011;4:486-501.
174. Lee J, Meyerhardt JA, Giovannucci E, Jeon JY. Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies [serial online]. PLoS One. 2015;10:e0120706.
175. Wu S, Liu J, Wang X, Li M, Gan Y, Tang Y. Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies. Cancer Causes Control. 2014;25:1489-1502.
176. Kroenke CH, Neugebauer R, Meyerhardt J, et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams. JAMA Oncol. 2016;2:1137-1145.
177. Majumder K, Gupta A, Arora N, Singh PP, Singh S. Premorbid obesity and mortality in patients with pancreatic cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:355.e-368.e; quiz e32.
178. Bae HS, Kim HJ, Hong JH, Lee JK, Lee NW, Song JY. Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis [serial online]. J Ovarian Res. 2014;7:41.
179. Nagle CM, Dixon SC, Jensen A, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer. 2015;113:817-826.
180. Fahey PP, Mallitt KA, Astell-Burt T, Stone G, Whiteman DC. Impact of pre-diagnosis behavior on risk of death from esophageal cancer: a systematic review and meta-analysis. Cancer Causes Control. 2015;26:1365-1373.
181. Choi Y, Park B, Jeong BC, et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer. 2013;132:625-634.
182. Hakimi AA, Furberg H, Zabor EC, et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst. 2013;105:1862-1870.
183. World Health Organization. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. Geneva, Switzerland: World Health Organization; 2013. apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf;jsessionid=B5C1A7F2BEFD729894E8CFBADF5ECD3B?sequence=1. Accessed July 1, 2018.
184. Kleinert S, Horton R. Rethinking and reframing obesity. Lancet. 2015;385:2326-2328.
185. Roberto CA, Swinburn B, Hawkes C, et al. Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking. Lancet. 2015;385:2400-2409.
186. World Health Organization. Tackling NCDs: “Best Buys” and Other Recommended Interventions for the Prevention and Control of Noncommunicable Diseases. Geneva, Switzerland: World Health Organization; 2017. who.int/ncds/management/best-buys/en/. Accessed July 1, 2018.
187. Gortmaker SL, Swinburn BA, Levy D, et al. Changing the future of obesity: science, policy, and action. Lancet. 2011;378:838-847.
188. Hawkes C, Smith TG, Jewell J, et al. Smart food policies for obesity prevention. Lancet. 2015;385:2410-2421.
189. World Health Organization. Governance: Development of a Draft Global Action Plan to Promote Physical Activity 2018–2030. Geneva, Switzerland: World Health Organization; 2018. who.int/ncds/governance/physical_activity_plan/en/. Accessed July 1, 2018.
190. Swinburn BA. Obesity prevention: the role of policies, laws and regulations [serial online]. Aust New Zealand Health Policy. 2008;5:12.
191. Swinburn B, Gill T, Kumanyika S. Obesity prevention: a proposed framework for translating evidence into action. Obes Rev. 2005;6:23-33.